PAX5 and neoplasm: Moreover, immunohistochemical analysis revealed that tumor cells were positive for CD20, CD79a, PAX5, CD21, and CD23 and expression of CD3, CD5, and CD8 were observed in reactive T lymphocytes surrounding tumor cells.